Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2278

1.

Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.

Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005533. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD005533.

PMID:
16235409
2.

Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.

Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005535. Review. Update in: Cochrane Database Syst Rev. 2010;(5):CD005535.

PMID:
16235410
3.
4.

Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.

Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD005533. doi: 10.1002/14651858.CD005533.pub2. Review.

5.

Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.

Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ.

Cochrane Database Syst Rev. 2010 May 12;(5):CD005535. doi: 10.1002/14651858.CD005535.pub2. Review.

6.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ram FS, Cates CJ, Ducharme FM.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003137. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003137.

PMID:
15674901
7.

Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.

Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM.

Cochrane Database Syst Rev. 2015 Nov 24;(11):CD007949. doi: 10.1002/14651858.CD007949.pub2. Review.

PMID:
26594816
8.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003137. Review. Update in: Cochrane Database Syst Rev. 2011;(5):CD003137.

PMID:
17054161
9.

Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.

Ni Chroinin M, Greenstone I, Lasserson TJ, Ducharme FM.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005307. doi: 10.1002/14651858.CD005307.pub2. Review.

10.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.

Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(20):1-174, iii-iv. Review.

11.

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2011 May 11;(5):CD003137. doi: 10.1002/14651858.CD003137.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003137.

PMID:
21563136
12.

Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children.

Ni Chroinin M, Lasserson TJ, Greenstone I, Ducharme FM.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007949. doi: 10.1002/14651858.CD007949. Review. Update in: Cochrane Database Syst Rev. 2015;11:CD007949.

13.

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

Chauhan BF, Ducharme FM.

Cochrane Database Syst Rev. 2014 Jan 24;(1):CD003137. doi: 10.1002/14651858.CD003137.pub5. Review.

PMID:
24459050
14.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.

15.

Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children.

Gibson PG, Powell H, Ducharme F.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005076. Review.

PMID:
16235393
16.

Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.

Chauhan BF, Chartrand C, Ducharme FM.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD009611. doi: 10.1002/14651858.CD009611.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD009611.

PMID:
23235678
17.

Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.

Chauhan BF, Chartrand C, Ducharme FM.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD009611. doi: 10.1002/14651858.CD009611.pub3. Review.

PMID:
23450606
18.

Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.

Kew KM, Dahri K.

Cochrane Database Syst Rev. 2016 Jan 21;(1):CD011721. doi: 10.1002/14651858.CD011721.pub2. Review.

PMID:
26798035
19.

Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.

Walters EH, Gibson PG, Lasserson TJ, Walters JA.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001385. Review.

PMID:
17253458
20.

Supplemental Content

Support Center